Physician profile
Clifford J Ruddle
NPI 1841561651
$21,003,687.21
in general payments reported to CMS, 2019-2025
6 companies · $1.5M in 2025
The $1.5M reported for 2025 was more than what 99% of Endodontics providers received nationally (typical 2025 total: $58.83).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4.3M · 2020: $3.4M · 2021: $4.0M · 2022: $3.0M · 2023: $2.6M · 2024: $2.2M · 2025: $1.5M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $6.0M · Consulting Fee: $300K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,969,382.03 |
| Consulting Fee | $300,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $14,483,157.82 | 2020-2025 | Protaper Universal, Waveone Gold Glider, Protaper Ultimate Treatment Covience Kit |
| Maillefer Instruments Holding Sarl | $5,456,086.95 | 2019-2021 | |
| Tulsa Dental Products LLC | $933,568.88 | 2019-2025 | Q-Mix |
| Vdw Gmbh | $129,710.61 | 2019 | |
| Dentsply Ih INC. | $1,067.45 | 2019 | |
| Dentsply US Prosthetics LLC | $95.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Ruddle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.